![HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] Solution.](/content/experience-fragments/takeda/hyqviacidphcp/language-masters/en/header/day-1-hcp-logo-and-indication/_jcr_content/root/container_1463398009/container/image.coreimg.svg/1706244319949/hyqvia-logo.svg){kind=logo}
![HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] Solution.](/hcp/_jcr_content/root/container/container_1907652875/container_2118205682/container/image.coreimg.svg/1707878882340/hyqvia-logo.svg){kind=logo}
HyQvia is now approved for the treatment of CIDP* as a maintenance therapy to prevent relapse of neuromuscular disability and impairment in adults.
*CIDP=chronic inflammatory demyelinating polyneuropathy.
HyQvia is newly approved, and may be reimbursed across sites of care,† to treat CIDP as maintenance therapy to prevent relapse of neuromuscular disability and impairment in adults. Could HyQvia be an option for your adult patients with CIDP? Explore the links below for more information.
Product Overview
Interested in seeing if HyQvia might be right for your patients with CIDP? The Product Overview has some helpful information for you.
Dosing and Administration Guide
This guide provides information a prescriber may need to determine dosing. In addition, a list of what is needed to infuse as well as a step-by-step guide to the process is included.
Access Brochure
In this brochure you will find all the information including how to determine HyQvia coverage by benefit, PA requirements, reimbursement guides, and more.
†Formulary status varies by plan and may be subject to change. Depending on a patient's medical and prescription drug benefit, prior authorization (PA) submission may be required before a patient can receive treatment with HyQvia.
Learn more about product support for your HyQvia patients
Need Assistance?
Our support specialists are never more than a tap or call away — 1-866-861-1750, Monday through Friday, 8 AM to 8 PM ET.
Need to enroll your patient after deciding to prescribe HyQvia?
Visit our convenient online enrollment portal at TakedaPatientSupport.com/hcp. You can also enroll your patient by faxing the completed Start Form to 1-855-268-1826.
If English is not your patient’s preferred language, we can assist them in a language of their choosing.
HyQvia may be reimbursed across multiple sites of care,|| including hospital, infusion centers, offices, or at home (HCP supported, or administered by the patient or their caregiver, after appropriate training)
||Formulary status varies by plan and may be subject to change. Depending on a patient's medical and prescription drug benefit, prior authorization (PA) submission may be required before a patient can receive treatment with HyQvia.
Stay Up to Date
Fill out and submit the necessary information below to stay up to date on HyQvia news.
*Required